Jason Mills

Stock Analyst at Canaccord Genuity

(3.91)
# 575
Out of 4,884 analysts
107
Total ratings
70.79%
Success rate
37.82%
Average return

Stocks Rated by Jason Mills

Penumbra
Feb 19, 2025
Maintains: Buy
Price Target: $323$340
Current: $251.06
Upside: +35.43%
TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $129.19
Upside: -15.63%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $17.86
Upside: +398.32%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $9.58
Upside: +192.28%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $142.47
Upside: +91.62%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $93.58
Upside: -41.23%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $3.40
Upside: +135.29%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $84.39
Upside: -64.45%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $544.47
Upside: -55.61%
LivaNova
Apr 30, 2020
Maintains: Hold
Price Target: $66$50
Current: $46.13
Upside: +8.39%
Maintains: Buy
Price Target: $41$45
Current: $31.76
Upside: +41.69%
Maintains: Buy
Price Target: $85$62
Current: $10.13
Upside: +512.04%
Maintains: Buy
Price Target: $43$46
Current: $104.32
Upside: -55.90%
Upgrades: Buy
Price Target: n/a
Current: $59.17
Upside: -